A Study of First Trimester Combined Screening for Down’s Syndrome in a Tertiary Care Hospital in South India.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2023 - 2025
Project Lead
Ms. Danishta Bashir
Authors
Ms. Danishta Bashir, Dr Jyothi D N, Dr Jikku Teresa
Project Status
completed
Project Type
Student Project